Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 1
2005 3
2006 5
2007 1
2008 6
2009 7
2010 5
2011 7
2012 4
2013 6
2014 4
2015 7
2016 11
2017 12
2018 12
2019 9
2020 16
2021 5
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: inokuchi k. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
Immunotherapy for Multiple Myeloma.
Tamura H, Ishibashi M, Sunakawa M, Inokuchi K. Tamura H, et al. Among authors: inokuchi k. Cancers (Basel). 2019 Dec 12;11(12):2009. doi: 10.3390/cancers11122009. Cancers (Basel). 2019. PMID: 31842518 Free PMC article. Review.
PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma.
Tamura H, Ishibashi M, Sunakawa-Kii M, Inokuchi K. Tamura H, et al. Among authors: inokuchi k. Cancers (Basel). 2020 Apr 10;12(4):924. doi: 10.3390/cancers12040924. Cancers (Basel). 2020. PMID: 32290052 Free PMC article. Review.
[Overview].
Inokuchi K. Inokuchi K. Rinsho Ketsueki. 2016;57(12):2517-2518. doi: 10.11406/rinketsu.57.2517. Rinsho Ketsueki. 2016. PMID: 28090020 Japanese. No abstract available.
[Chronic myeloid leukemia: up-to-date management].
Nakayama K, Inokuchi K. Nakayama K, et al. Among authors: inokuchi k. Rinsho Ketsueki. 2014 Jan;55(1):42-55. Rinsho Ketsueki. 2014. PMID: 24492036 Review. Japanese. No abstract available.
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.
Yoshida C, Yamaguchi H, Doki N, Murai K, Iino M, Hatta Y, Onizuka M, Yokose N, Fujimaki K, Hagihara M, Oshikawa G, Murayama K, Kumagai T, Kimura S, Najima Y, Iriyama N, Tsutsumi I, Oba K, Kojima H, Sakamaki H, Inokuchi K; Kanto CML Study Group. Yoshida C, et al. Among authors: inokuchi k. Int J Hematol. 2023 May;117(5):694-705. doi: 10.1007/s12185-023-03549-3. Epub 2023 Feb 4. Int J Hematol. 2023. PMID: 36739328 Free PMC article. Clinical Trial.
[Myeloid diseases. Overview].
Inokuchi K. Inokuchi K. Rinsho Ketsueki. 2013 Jan;54(1):37-8. Rinsho Ketsueki. 2013. PMID: 23391645 Japanese. No abstract available.
11q23/MLL acute leukemia : update of clinical aspects.
Tamai H, Inokuchi K. Tamai H, et al. Among authors: inokuchi k. J Clin Exp Hematop. 2010;50(2):91-8. doi: 10.3960/jslrt.50.91. J Clin Exp Hematop. 2010. PMID: 21123966 Free article. Review.
115 results